ubmslateRN-logo-ubm

RN Mobile Menu

Search form

Topics:

Psoriatic Arthritis

Statins with TNFa Treatment Lowers LDL levels in PsA

TNF-α inhibitor treatment in PsA, RA and AS may be associated with a significant increase in total cholesterol, triglyceridesand the atherogenic index. Statins with treatment lowered LDL levels. (©CreateJobs51/Shutterstock.com)

Psoriatic Arthritis

©SutthaBurawonk/Shutterstock.com

Psoriatic spondyloarthritis forms part of the spondyloarthritis spectrum, between peripheral-only psoriatic arthritis and ankylosing spondylitis.

Up to 30% of psoriasis patients will develop psoriatic arthritis. Studies show that a proportion of patients in clinical care have undiagnosed PsA.

TNF-α inhibitor treatment in PsA, RA and AS may be associated with a significant increase in total cholesterol, triglyceridesand the atherogenic index. Statins with treatment lowered LDL levels.

Redefining disease remission or inactivity examined in this assessment by Laura Coates of the University of Leeds.

Guselkumab significantly improved joint symptoms, physical function, psoriasis, enthesitis, dactylitis and quality of life in patients with active psoriatic arthritis, researchers report.

Researchers find that apremilast and CF101 both are safe and effective for psoriasis, but apremilast outperforms CF101 through 16 weeks, until it plateaus.

Pages

Subscribe to Psoriatic Arthritis on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.